BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26551491)

  • 1. Diagnosis and management of hepatitis C.
    Vine LJ; Sieberhagen C; Cramp ME
    Br J Hosp Med (Lond); 2015 Nov; 76(11):625-30. PubMed ID: 26551491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The "C" of viral hepatitis in children.
    Narkewicz MR; Cabrera R; González-Peralta RP
    Semin Liver Dis; 2007 Aug; 27(3):295-311. PubMed ID: 17682976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of drug resistance and novel approaches to therapy for chronic hepatitis C.
    Locarnini SA
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl 3():S351-9. PubMed ID: 12472963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revolutionizing treatment outcomes in hepatitis C: managed care implications and considerations--diagnosis and management.
    Shah M; Younossi ZM
    Am J Manag Care; 2015 Mar; 21(5 Suppl):S86-96. PubMed ID: 26167958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C virus infection in children.
    Mohan N; González-Peralta RP; Fujisawa T; Chang MH; Heller S; Jara P; Kelly D; Mieli-Vergani G; Shah U; Murray KF
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):123-31. PubMed ID: 20038846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-stimulated gene 15: a dual activity during hepatitis C virus infection.
    Estrabaud E; Asselah T
    Gut; 2010 Aug; 59(8):1017-9. PubMed ID: 20639247
    [No Abstract]   [Full Text] [Related]  

  • 7. Viral changes causing chronic hepatitis C.
    Cockey CD
    AWHONN Lifelines; 2000; 4(4):20-1. PubMed ID: 11898280
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic viral hepatitis.
    Dakhil N; Junaidi O; Befeler AS
    Mo Med; 2009; 106(5):361-5. PubMed ID: 19902718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection.
    Fernández-Yunquera A; Rincón D; Salcedo M; Bañares R
    Rev Esp Quimioter; 2013 Sep; 26(3):189-92. PubMed ID: 24080883
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations.
    Torres HA; Chong PP; De Lima M; Friedman MS; Giralt S; Hammond SP; Kiel PJ; Masur H; McDonald GB; Wingard JR; Gambarin-Gelwan M
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1870-82. PubMed ID: 26256943
    [No Abstract]   [Full Text] [Related]  

  • 11. [An update on the management of chronic hepatitis C].
    Bihl F; Pache I; Hess J; Moradpour D
    Rev Med Suisse; 2010 Jan; 6(233):174, 176-9. PubMed ID: 20214188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiviral treatment of chronic hepatitis C].
    Berger A
    Med Monatsschr Pharm; 2012 Feb; 35(2):55-60. PubMed ID: 22400430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus drug resistance: implications for clinical management.
    Wyles DL
    Infect Dis Clin North Am; 2012 Dec; 26(4):967-78. PubMed ID: 23083827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virological relapse in chronic hepatitis C.
    Poordad FF; Flamm SL
    Antivir Ther; 2009; 14(3):303-13. PubMed ID: 19474464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for ribavirin in the era of hepatitis C virus direct-acting antivirals?
    Feld JJ
    Gastroenterology; 2012 May; 142(6):1356-9. PubMed ID: 22537443
    [No Abstract]   [Full Text] [Related]  

  • 16. Cause-effect relationship between the hepatitis C virus and insulin resistance at the time of direct antiviral therapy.
    Negro F
    Gut; 2010 Dec; 59(12):1590-1. PubMed ID: 20926646
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents.
    Juan J; Feld JJ
    Curr Opin Rheumatol; 2014 Jul; 26(4):395-403. PubMed ID: 24841230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
    Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
    J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic approaches for hepatitis C.
    Au JS; Pockros PJ
    Clin Pharmacol Ther; 2014 Jan; 95(1):78-88. PubMed ID: 24126682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asunaprevir-containing regimens for the treatment of hepatitis C virus infection.
    Yang SS; Kao JH
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):9-20. PubMed ID: 25174254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.